Top Markets
Coin of the day
Prince Pharmaceutical Co., Ltd. Prince Pharmaceutical Co., Ltd.

Prince Pharmaceutical Co., Ltd.

6935
Classifica tra le azioni #27309
Prince Pharmaceutical Co., Ltd. operates in the production and global sale of... Prince Pharmaceutical Co., Ltd. operates in the production and global sale of active pharmaceutical ingredients (APIs), primarily focusing on vitamin B1. Its market presence extends across Taiwan, Japan, Korea, and other international territories. The company's product portfolio also encompasses a variety of consumer health items and general medicines. These offerings include popular formulations such as vitamin C tablets and vitamin B complex tablets, alongside specialized supplements like natto and rhodiola extract capsules, probiotic sachets, and various plant extract capsules. In addition to vitamin B1, Prince Pharmaceutical supplies a comprehensive array of other APIs, notably felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. The company's distribution network specifically includes countries within Spain and the wider European continent. Established in 1962, Prince Pharmaceutical Co., Ltd. is based in Yunlin County, Taiwan.
Prezzo delle azioni
$0.89991249
Capitalizzazione di mercato
$33.67M
Variazione (1 giorno)
-0.35%
Variazione (1 anno)
7.33%
Paese
TW
Scambia Prince Pharmaceutical Co., Ltd. (6935)

Categoria

EPS per Prince Pharmaceutical Co., Ltd. (6935)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Prince Pharmaceutical Co., Ltd., l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Prince Pharmaceutical Co., Ltd. da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti